Phthisis Diagnostics founder Eric Houpt with Crystal Icenhour, president and director of research. Phthisis Diagnostics is a molecular diagnostics research and development company that develops products for various infectious diseases. Molecular technology presents significant advantages to laboratories in superior quality, ease-of-use, and significant cost savings.
Read More >>
T100 Spotlight Archive >> |
|
Under the direction of the VP for Research, the T100 Alumni Mentoring Program offers U.Va alumni the opportunity to guide commercial ventures that have research origins at the University. T100 members provide hands-on mentoring to support faculty ventures as they evolve from concept to commercial enterprise. Team members participate in a monthly conference call to help advance the commercial promise of the technology.
JOIN T100 Interested alumni are encouraged to inquire about mentorship opportunities. Faculty entrepreneurs should contact us to find out about the resources available through T100 to support commercializable technologies. Find out more.
CONTRAVAC'S HOME MALE FERTILITY TEST GOES NATIONAL (2/7/12) This one-of-a-kind test for male fertility will soon be available on retail shelves throughout the country.
SPHYNKX THERAPEUTICS RECEIVES FUNDING FROM CIT GAP FUND (1/18/12) Center for Innovative Technology will invest $50,000 in Sphynkx to advance treatment of cancer and fibrosis.
CIT SELECTS ALUMNI MENTORED COMPANIES FOR COMMERCIALIZATION FUNDS (12/21/11) HemoSonics and Phthisis Diagnostics have received funding to advance their commercial potential.
GRANT RECEIVED TO SUPPORT INNOVATIVE HOUSING DESIGNS (7/12/11) The Virginia Tobacco Commission has awarded a $2.5 million grant to UVa to support ecoMOD and Initiative reCOVER energy-efficient housing and disaster recovery designs.
READ MORE T100 NEWS
|
